Addex Shareholders Approve All Resolutions at Annual
Addex Therapeutics shareholders approved all board proposals at the 2026 Annual General Meeting, including financial reports and the re-election of directors. The company also passed amendments to its Articles of Association regarding capital structure.
Why it matters
Corporate governance stability is critical for clinical-stage biopharmaceutical companies as they manage long-term research and development funding.
Ad Hoc Announcement Pursuant to Art. 53 LR
The content is a standard corporate disclosure of shareholder voting results.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in